|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RECEPTORS AND SIGNAL TRANSDUCTION
1Department of Medicine and 2Center for Free Radical Biology,University of Alabama at Birmingham, Birmingham, Alabama; 3Pole Anesthésie Réanimation du Centre Hospitalier Universitaire and 4Institut National de la Santé et de la Recherche Médicale, Amiens, France
Submitted 1 October 2007 ; accepted in final form 13 February 2008
| ABSTRACT |
|---|
|
|
|---|
B (NF-
B) and increased neutrophil production of the NF-
B-dependent cytokines tumor necrosis factor-
(TNF-
) and macrophage inhibitory protein-2 (MIP-2). In contrast, there were no changes in TNF-
or MIP-2 expression when neutrophils lacking Toll-like receptor-4 (TLR4) were exposed to extracellular superoxide. Immunoprecipitation, confocal microscopy, and fluorescence resonance energy transfer (FRET) studies demonstrated association between TLR4 and xanthine oxidase. Exposure of neutrophils to heparin attenuated binding of xanthine oxidase to the cell surface as well as interactions with TLR4. Heparin also decreased xanthine oxidase-induced nuclear translocation of NF-
B as well as production of proinflammatory cytokines. These results demonstrate that extracellular superoxide has proinflammatory effects on neutrophils, predominantly acting through an TLR4-dependent mechanism that enhances nuclear translocation of NF-
B and increases expression of NF-
B-dependent cytokines.
reactive oxygen species; Toll-like receptor-4; nuclear factor-
b; signal transduction; heparin; glycosaminoglycans
Alterations in the intracellular levels of specific ROS appear to have distinct effects on neutrophil function. For example, increased intracellular concentrations of superoxide result in activation of nuclear factor-
B (NF-
B) and enhanced proinflammatory cytokine production (23). In contrast, exposure of neutrophils to hydrogen peroxide, which can cross the cell membrane to increase intracellular hydrogen peroxide levels, results in inhibition of proteasomal activity and attenuation of I
B-
degradation upon Toll-like receptor-4 (TLR4) engagement, as well as decreased nuclear translocation of NF-
B- and LPS-induced proinflammatory cytokine production (44).
Unlike hydrogen peroxide, which is able to rapidly diffuse across cell membranes, superoxide, as a charged species, is unable to transit from extracellular to intracellular sites. In vivo studies have demonstrated that superoxide generation in the extracellular milieu is proinflammatory. For example, intestinal ischemia-reperfusion or large volume blood loss results in increased circulating concentrations of xanthine, hypoxanthine, xanthine oxidase, systemic production of superoxide, and the development of acute lung injury (4, 24, 29, 34). However, it has not been determined whether the proinflammatory effects associated with xanthine oxidase release are directly due to cellular interactions with superoxide, to increased production of hydrogen peroxide and other ROS that then affect cellular function, or to induction of secondary proinflammatory pathways initiated by cellular contact with xanthine oxidase.
The present studies were designed to examine the mechanisms by which extracellular superoxide results in neutrophil activation. We found that generation of superoxide through direct interaction of xanthine oxidase with TLR4 resulted in enhanced activation of NF-
B and production of NF-
B-dependent proinflammatory cytokines.
| MATERIALS AND METHODS |
|---|
|
|
|---|
or MIP-2 were from R&D Systems (Minneapolis, MN). The antibodies to TLR4 (H-80), TLR5 (300 m), xanthine oxidase (T-17), and p65 (C-20) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Alexa 488-labeled anti-rabbit and Alexa 555-labeled anti-goat antibodies were purchased from Invitrogen (Eugene, OR). Custom antibodies for neutrophil isolation were purchased from StemCell Technologies (Vancouver, BC, Canada). Isoflurane was obtained from Abbott Laboratories (Chicago, IL). Animals. Male C57/BL6, C57/10Scn (TLR4–/–), and C57/10J (TLR4+/+) mice, 10–12 wk of age, were purchased from Jackson Laboratory (Bar Harbor, ME) (28). The mice were kept on a 12-h light, 12-h dark cycle with free access to food and water. All experiments were conducted in accordance with institutional review board-approved protocols.
Neutrophil isolation and culture. Bone marrow neutrophils were isolated from the hips, femurs, and tibias of 8- to 12-wk-old mice and purified by negative selection using primary antibodies specific for the cell surface markers F4/80, CD4, CD45R, CD5, and TER119 StemCell Technologies as described previously (44). Neutrophil purity, as determined by Wright-Giemsa-stained cytospin preparations, was consistently >97%. Neutrophils were also isolated from the peritoneal cavity of mice 4 h after intraperitoneal injection with 2 ml of thioglycolate solution (3%). The peritoneal cell populations were consistently composed of >97% neutrophils. Neutrophils were cultured in RPMI 1640 medium containing FBS (0.5%) and treated as described in the figures. The cell viability was determined using a trypan blue staining and was consistently >95%.
Measurement of superoxide generated by hypoxanthine-xanthine oxidase system.
The superoxide generated by hypoxanthine-xanthine oxidase system was measured in culture medium (RPMI-1640, 0.5% FBS) by using the superoxide-dependent reduction of cytochrome c assay (22). Briefly, the reaction was initiated in samples containing xanthine oxidase (1, 3, or 10 mU/ml), hypoxanthine (500 µM), and cytochrome c (10 µM), and the rate of cytochrome c reduction was recorded (
= 550 nm,
M = 21 mM–1·cm–1) using a spectrophotometer (UV-2501PC Shimadzu; Shimadzu, Japan) for 10 min at 37°C. The concentration of superoxide was calculated by using a standard of reduced cytochrome c (Sigma), and superoxide production was corrected by subtraction of the superoxide dismutase (SOD, 256 mU/ml) insensitive rates. The rates of superoxide generated by 1, 3, or 10 mU/ml hypoxanthine-xanthine oxidase system were
0.13, 0.51, or 0.92 nmol–1·min–1·ml–1, respectively.
Cytokine ELISA.
TNF-
and macrophage inhibitory protein (MIP-2) were quantified using commercially available ELISA kits (R&D Systems, Minneapolis, MN), according to the manufacturer's instructions and as described previously (38, 43, 44).
Nuclei isolation and Western blot analysis. Nuclear proteins were purified from 7 x 106 neutrophils as described previously (44). The protein concentration in the nuclear extracts was determined using Bradford reagent (Bio-Rad, Hercules, CA) with BSA as a standard. Samples were mixed with Laemmli sample buffer and boiled for 5 min. Equal amounts of proteins were resolved by 10% SDS-polyacrylamide gel electrophoresis and transferred onto PVDF membranes (Immobilon P, Millipore, Billerica, MA). The membranes were probed with specific antibodies to p65 (Santa Cruz, CA) followed by detection with horseradish peroxidase-conjugated goat anti-rabbit IgG. Bands were visualized by enhanced chemiluminescence (ECL plus, Amersham) and quantified by AlphaEaseFC Software (Alpha Innotech, San Leandro, CA). Each experiment was performed three or more times using cell populations obtained from separate groups of mice.
Electrophoretic mobility shift assay.
Nuclear extracts were obtained from C57/10Scn (TLR4–/–) and C57/10J (TLR4+/+) bone marrow neutrophils after culture with or without xanthine oxidase. Electrophoretic mobility shift assay (EMSA) was performed as reported previously (35, 40, 42). In brief, the
B DNA sequence of the Ig gene was used. Synthetic double-stranded oligonucleotide probes for the
B site were filled in and were [32P]dATP end labeled (GE Healthcare) using Sequenase DNA polymerase:
B sequence, 5'-GCCATGGGGGGATCCCCGAAGTCC-3' (Geneka Biotechnology).
Immunoprecipitation assay (IP). TLR4+/+ and TLR4–/– bone marrow neutrophils (15 x 106) were incubated with xanthine oxidase (60 mU) for 15 min. TLR4 was then immunoprecipitated from the cell lysates, as described previously with minor modifications (26). In brief, neutrophils were lysed in immunoprecipitation (IP) buffer (20 mM Tris·HCl, pH 8.0, 137 mM NaCl, 2 mM EDTA, 5% glycerol, and 0.1% NP40) containing protease inhibitors (Roche, Mannheim, Germany). To remove insoluble particles, cell extracts were centrifuged (14,000 rpm) for 15 min at 4°C. TLR4 was immunoprecipitated by incubation of cell extracts (500 µg) with anti-TLR4 antibodies overnight at 4°C followed by incubation with recombinant protein A agarose (Invitrogen) for 2 h at 4°C. The immunoprecipitates were washed three times with IP buffer, boiled in x2 Laemmli buffer (40 µl), and then subjected to Western blot analysis.
Immunofluorescence microscopy and fluorescence resonance energy transfer analysis. Bone marrow neutrophils were cultured on coverslips in RPMI 1640 media supplemented with FBS (0.5%) and treated as indicated in the figure legends. Cells were then fixed with paraformaldehyde (4%) for 45 min. To detect cell membrane localization of xanthine oxidase, TLR4, or TLR5, samples were subsequently incubated with PBS containing 5% bovine serum albumin (BSA) for 30 min followed by incubation for 1 h at room temperature with antibodies specific for xanthine oxidase (T-17), TLR4 (H-80), or TLR5 (300 m). Coverslips were washed three times with PBS and then incubated with Alexa 488- and Alexa 555-labeled secondary antibodies for 1 h at room temperature. Antibodies were diluted 1:100 in PBS containing 5% BSA. The coverslips were mounted using a solution of PBS containing n-propyl gallate (0.2%) and glycerol (90%, vol/vol). Images were acquired by four bidirectional scans of the cells with the use of a Leica DMIRBE inverted epifluorescence/Nomarski microscope outfitted with Leica TCS NT laser confocal optics (absorption/emission filters: green 480/500 nm or red 561/570 nm). Images were merged and digital processing was performed using Adobe Photoshop (Adobe Systems, San Jose, CA) software.
Fluorescence resonance energy transfer (FRET) analysis (33) was used to measure proximity between TLR4 or TLR5 with xanthine oxidase bound to the cell surface. Samples for FRET analysis were prepared as for confocal microscopy, as described above. The baseline fluorescence (prebleach) of xanthine oxidase (Alexa 555) and TLR4 or TLR5 (Alexa 488) were measured using excitation/emission at 561/575-714 nm or 480/500-535 nm, respectively. Half of the cell was then exposed to high-energy excitation at 561 nm (Alexa 550, acceptor fluorochrome) to transfer energy to Alexa 488 (donor fluorochrome). After this bleaching process, emission intensity of the Alexa 555 and 488 fluorochromes was measured (postbleach). Bleaching of Alexa 555 was confirmed by being <30% of initial intensity. The increased fluorescence of Alexa 488 was determined by calculation of FRET efficiency using LEICA confocal software and formulas where the difference between values obtained from postbleach and prebleach were divided by the postbleach intensity. FRET efficiency from the nonexcited part of the cell was used to subtract the background. Data were averaged from at least 12 cells from three coverslips.
Statistical analysis. For each experiment, neutrophils were isolated and pooled from groups of mice (n = 3–4 mice in each group). One-way analysis of variance, the Tukey-Kramer Multiple Comparisons test (for multiple groups), or Student's t-test (for comparisons between two groups) were used. P < 0.05 was considered to be statistically significant.
| RESULTS |
|---|
|
|
|---|
and MIP-2 production in a dose-dependent manner (Fig. 1, A–D). Culture of peritoneal neutrophils with xanthine oxidase and hypoxanthine also resulted in increased generation of TNF-
and MIP-2 (Fig. 1, E and F). In these experiments, cellular viability was consistently >95% after 6 h of culture with all concentrations of xanthine oxidase (0, 3, and 10 mU/ml).
|
B participates in the transcriptional regulation of TNF-
and MIP-2 (9, 11), we evaluated nuclear translocation of NF-
B in neutrophils cocultured with hypoxanthine and xanthine oxidase. As shown in Fig. 2, exposure of neutrophils to hypoxanthine-xanthine oxidase resulted in enhanced nuclear localization of the NF-
B p65 subunit in a dose-dependent manner (Fig. 2). The proinflammatory effects of the hypoxanthine-xanthine oxidase combination were directly due to the catalytic activity of xanthine oxidase since inclusion of allopurinol, a specific inhibitor of xanthine oxidase, into the neutrophil cultures completely inhibited generation of TNF-
and MIP-2 (Fig. 3, A and B).
|
|
TLR4 participates in the activation of neutrophils by xanthine oxidase. Previous in vivo studies indicated that TLR4 was involved in hemorrhage-induced acute lung injury, a situation in which there are increased circulating concentrations of xanthine oxidase but no detectible LPS in plasma (4). Such findings suggested that interactions between TLR4 and reactive oxygen intermediates generated by xanthine oxidase might contribute to the production of proinflammatory cytokines in the lungs and the development of acute lung injury.
To examine the role of interactions between TLR4 and extracellular superoxide in cellular activation, neutrophils from TLR4–/– C57/10Scn (28) and control TLR4+/+ C57/10J mice were cultured with hypoxanthine-xanthine oxidase. As shown in Fig. 4, A–C, TNF-
and MIP-2 generation as well as NF-
B activation following neutrophil coculture with hypoxanthine and xanthine oxidase were significantly decreased in TLR4–/– compared with TLR4+/+ neutrophils.
|
|
Effects of heparin on membrane-bound xanthine oxidase and xanthine oxidase-mediated cytokine production by neutrophils. Xanthine oxidase is known to bind to glycosaminoglycans in the extracellular matrix (2, 30). Heparin has been shown to compete with xanthine oxidase for binding to glycosaminoglycans (2, 30, 31). Under in vivo conditions, intravascular injection of heparin releases xanthine oxidase from endothelial cells and leads to an increase in circulating concentrations of xanthine oxidase (2).
To test whether heparin potentially releases membrane-bound xanthine oxidase from neutrophils, cells were incubated with xanthine oxidase in the presence or absence of heparin, and the activity of xanthine oxidase in supernatants was determined using the cytochrome c reduction assay. In the absence of cells, addition of heparin to culture media had no effect on the rate of superoxide production by the combination of xanthine oxidase and hypoxanthine (Fig. 6A). In contrast, the rate of superoxide production was increased in the supernatants collected from neutrophils coincubated with heparin (Fig. 6B). Moreover, addition of heparin to neutrophils cocultured with hypoxanthine-xanthine oxidase resulted in decreased nuclear translocation of NF-
B (Fig. 6, E and F) as well as diminished production of TNF-
and MIP-2 compared with that induced by hypoxanthine-xanthine oxidase alone (Fig. 6, C and D).
|
|
| DISCUSSION |
|---|
|
|
|---|
B as well as the production of proinflammatory cytokines in neutrophils. The mechanism for the proinflammatory effects of superoxide appeared to be through association of xanthine oxidase with TLR4. In particular, confocal microscopy and FRET studies demonstrated direct interaction between TLR4 and xanthine oxidase on the cell surface, and neutrophil activation by exposure to the superoxide generating combination of hypoxanthine-xanthine oxidase was decreased to near baseline levels in TLR4-deficient neutrophils.
In previous experiments, we found that incubation of neutrophils with paraquat, an intracellular generator of superoxide, increased NF-
B activation and proinflammatory cytokine secretion (23). Paraquat also enhanced TLR4-mediated nuclear translocation of NF-
B and expression of NF-
B-dependent cytokines, such as TNF-
and MIP-2, consistent with a proinflammatory effect for intracellularly generated superoxide in neutrophils (23). However, the effects of extracellular superoxide on neutrophil activation have not been previously reported. In vivo studies indicated that increased extracellular superoxide production accompanies hemorrhage-induced acute lung injury, a condition in which activated neutrophils play a central role and circulating concentrations of xanthine oxidase, but not LPS, are increased (4, 32).
In vitro studies, from our laboratory and others, have shown that cellular exposure to the superoxide-generating combination of xanthine-xanthine oxidase could induce NF-
B activation in splenocytes, NF-
B-dependent cytokine generation in smooth muscle cells and monocytes, as well as enhanced NF-
B/DNA binding activity in podocytes (12, 18, 20, 25, 35). Because superoxide is unable to diffuse across membranes, we did not expect that extracellular superoxide could directly affect intracellular signaling pathways. The present experiments confirmed this hypothesis by demonstrating that the mechanism through which extracellular superoxide induced neutrophil activation was by association with cell surface TLR4 and activation of TLR4-linked pathways that lead to activation of NF-
B.
The association of xanthine oxidase with TLR4 on the neutrophil membrane appears to occur through binding to glycosaminoglycans, as shown by reduction of FRET efficiency between xanthine oxidase and TLR4 when neutrophils were preincubated with heparin. Such interactions between xanthine oxidase and glycosaminoglycans on the cell surface also provide an explanation for the inability of allopurinol, when added to the cultures, to suppress completely hypoxanthine-xanthine oxidase-induced neutrophil activation. In particular, binding of xanthine oxidase to glycosaminoglycans has been shown to limit inhibition of xanthine oxidase activity by oxipurinol (16). In addition, there is diminished ability of allopurinol to block the catalytic, superoxide-producing activity of endothelial cell bound xanthine oxidase (15). In the present experiments, incubating xanthine oxidase with allopurinol for 4 h before addition to cell cultures completely prevented its ability to stimulate neutrophil activation. In contrast, addition of allopurinol with or immediately after inclusion of xanthine oxidase in the cell cultures was unable to affect xanthine oxidase-induced increases of NF-
B activation and cytokine production (data not shown). These observations, which are consistent with membrane-associated xanthine oxidase being relatively inaccessible to allopurinol, could provide at least a partial explanation for lack of efficacy of allopurinol in decreasing organ dysfunction after severe accidental trauma, a situation associated with increased circulating, and presumably cell-bound concentrations of xanthine oxidase (13, 39).
In these studies, we used CuZn-superoxide dismutase and catalase to determine the specific roles of superoxide and hydrogen peroxide in xanthine oxidase-induced neutrophil activation. Other laboratories have shown that the binding of xanthine oxidase to endothelial cells decreases the inhibitory efficiency of CuZn-SOD so that it is only able to diminish xanthine oxidase-induced superoxide generation by about 30% (30). Such findings suggested that glycosaminoglycan-bound xanthine oxidase partitions into a SOD-resistant compartment (15, 30). Consistent with such previous findings, we found that CuZn-SOD was less efficient in decreasing xanthine oxidase-induced superoxide generation in the presence of neutrophils compared with conditions where neutrophils were absent. Similarly, CuZn-SOD significantly decreased, but did not eliminate, the effects of xanthine oxidase on cytokine generation by neutrophils. Of note, no additional inhibitory effects of CuZn-SOD on cytokine production by hypoxanthine-xanthine oxidase-stimulated neutrophils were found even when the concentration of Cu-Zn SOD in the culture media was increased to 500 U/ml (data not shown). Catalase did not affect cytokine production by neutrophils coincubated with hypoxanthine-xanthine oxidase, indicating that hydrogen peroxide does not contribute to the potentiating effects of xanthine oxidase. These results are consistent with our previous studies that found no effect of catalase on xanthine-xanthine oxidase-induced NF-
B activation in splenocytes (35). Of note, incubation of neutrophils with catalase produced enhanced production of TNF-
and MIP-2. These findings are similar to those reported in our previous study that found a two- to threefold increase in TNF-
and MIP-2 by catalase-treated neutrophils (44). These effects of catalase on the production of NF-
B-dependent cytokines are likely to result from enhanced proteasomal-associated degradation of I
B-
as a result of diminished intracellular levels of hydrogen peroxide. In particular, our previous studies (44) showed that hydrogen peroxide had inhibitory effects on proteasomal function and degradation of I
B-
, both in LPS-treated and resting neutrophils; treatment of cells with catalase, which results in decreased intracellular concentrations of hydrogen peroxide, therefore would be expected to be associated with enhanced proteasomal degradation of I
B-
and increased activation of NF-
B.
The present experiments demonstrate that TLR4 is centrally involved in mediating the proinflammatory effects of extracellular superoxide. Such results are consistent with previous studies indicating a role for TLR4 in oxidant-induced organ dysfunction. For example, TLR4 was shown to participate in hemorrhage-induced neutrophil activation and increases in pulmonary concentrations of TNF-
and the development of acute lung injury, a situation in which circulating concentrations of xanthine oxidase and production of ROS are increased, even though there is no detectible LPS in plasma (4). In vivo studies demonstrated that therapy with eritoran, a specific TLR4-MD2 inhibitor, attenuated myocardial ischemia-reperfusion injury (36). Similarly, infarction size after coronary ligation was decreased in C3H/HeJ mice that express a nonfunctional TLR4 when compared with that of control C3H/HeN mice (37).
In the present experiments, we found that xanthine oxidase colocalizes and interacts with TLR4 on the cell surface of neutrophils. The association of xanthine oxidase and TLR4 provides a direct mechanism whereby xanthine oxidase-mediated superoxide production can affect TLR4-related signaling events, especially given the extremely short half-time of superoxide, before dismutation to hydrogen peroxide occurs. However, despite the evidence provided in this study that xanthine oxidase-derived superoxide activates neutrophils, the actual mechanism through which superoxide affects TLR4 signaling, including the extracellular domain of TLR4 involved, remains an important question for future investigation.
This study is the first to show direct binding of xanthine oxidase to neutrophils via a glycosaminoglycan-mediated mechanism. Binding of xanthine oxidase to the surface of endothelial cells is also mediated by glycosaminoglycans and is reversible by cell exposure to heparin (2, 30, 31). Addition of heparin to endothelial cells in vitro releases free xanthine oxidase into the culture media (2, 30). Similarly, injection of human subjects with heparin results in increased plasma concentrations of xanthine oxidase (2). In the present experiments, we found that heparin decreases the binding of xanthine oxidase to neutrophils and also diminishes xanthine oxidase-mediated cytokine production. Confocal microscopy and FRET analysis demonstrated that addition of heparin to xanthine oxidase-exposed neutrophils decreased the interaction between TLR4 and xanthine oxidase, thus providing a mechanism for the inhibitory effects of heparin on xanthine oxidase-induced cellular activation. Such findings suggest that therapy with heparin may be beneficial in diminishing the severity of acute inflammatory responses in pathophysiological conditions, such as sepsis and acute lung injury, in which xanthine oxidase and neutrophils play a contributory role. Of note, several analyses of large cohorts of septic patients have indicated that heparin administration is associated with reduced mortality (1, 27, 41). The present studies suggest that a potential mechanism for this beneficial effect on patient outcome is through reducing xanthine oxidase-induced TLR4-dependent neutrophil activation.
| GRANTS |
|---|
|
|
|---|
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
| REFERENCES |
|---|
|
|
|---|
2. Adachi T, Fukushima T, Usami Y, Hirano K. Binding of human xanthine oxidase to sulphated glycosaminoglycans on the endothelial-cell surface. Biochem J 289: 523–527, 1993.[Web of Science][Medline]
3. Andreadis AA, Hazen SL, Comhair SA, Erzurum SC. Oxidative and nitrosative events in asthma. Free Radic Biol Med 35: 213–225, 2003.[CrossRef][Web of Science][Medline]
4. Barsness KA, Arcaroli J, Harken AH, Abraham E, Banerjee A, Reznikov L, McIntyre RC. Hemorrhage-induced acute lung injury is TLR-4 dependent. Am J Physiol Regul Integr Comp Physiol 287: R592–R599, 2004.
5. Berg K, Wiseth R, Bjerve K, Brurok H, Gunnes S, Skarra S, Jynge P, Basu S. Oxidative stress and myocardial damage during elective percutaneous coronary interventions and coronary angiography. A comparison of blood-borne isoprostane and troponin release. Free Radic Res 38: 517–525, 2004.[CrossRef][Web of Science][Medline]
6. Berges A, Van Nassauw L, Bosmans J, Timmermans JP, Vrints C. Role of nitric oxide and oxidative stress in ischaemic myocardial injury and preconditioning. Acta Cardiol 58: 119–132, 2003.[CrossRef][Web of Science][Medline]
7. Cadenas S, Cadenas AM. Fighting the stranger-antioxidant protection against endotoxin toxicity. Toxicology 180: 45–63, 2002.[CrossRef][Web of Science][Medline]
8. Cowley HC, Bacon PJ, Goode HF, Webster NR, Jones JG, Menon DK. Plasma antioxidant potential in severe sepsis: a comparison of survivors and nonsurvivors. Crit Care Med 24: 1179–1183, 1996.[CrossRef][Web of Science][Medline]
9. De Plaen IG, Han XB, Liu X, Hsueh W, Ghosh S, May MJ. Lipopolysaccharide induces CXCL2/macrophage inflammatory protein-2 gene expression in enterocytes via NF-kappaB activation: independence from endogenous TNF-alpha and platelet-activating factor. Immunology 118: 153–163, 2006.[CrossRef][Web of Science][Medline]
10. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 82: 47–95, 2002.
11. Ghosh S, Karin M. Missing pieces in the NF-kappaB puzzle. Cell 109, Suppl: S81–S96, 2002.[CrossRef][Web of Science][Medline]
12. Greiber S, Muller B, Daemisch P, Pavenstadt H. Reactive oxygen species alter gene expression in podocytes: induction of granulocyte macrophage-colony-stimulating factor. J Am Soc Nephrol 13: 86–95, 2002.
13. Guan W, Osanai T, Kamada T, Hanada H, Ishizaka H, Onodera H, Iwasa A, Fujita N, Kudo S, Ohkubo T, Okumura K. Effect of allopurinol pretreatment on free radical generation after primary coronary angioplasty for acute myocardial infarction. J Cardiovasc Pharmacol 41: 699–705, 2003.[CrossRef][Web of Science][Medline]
14. Hille R, Massey V. Studies on the oxidative half-reaction of xanthine oxidase. J Biol Chem 256: 9090–9095, 1981.
15. Houston M, Estevez A, Chumley P, Aslan M, Marklund S, Parks DA, Freeman BA. Binding of xanthine oxidase to vascular endothelium. Kinetic characterization and oxidative impairment of nitric oxide-dependent signaling. J Biol Chem 274: 4985–4994, 1999.
16. Kelley EE, Trostchansky A, Rubbo H, Freeman BA, Radi R, Tarpey MM. Binding of xanthine oxidase to glycosaminoglycans limits inhibition by oxypurinol. J Biol Chem 279: 37231–37234, 2004.
17. Kirkham P, Rahman I. Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy. Pharmacol Ther 111: 476–494, 2006.[CrossRef][Web of Science][Medline]
18. Kosmidou I, Vassilakopoulos T, Xagorari A, Zakynthinos S, Papapetropoulos A, Roussos C. Production of interleukin-6 by skeletal myotubes: role of reactive oxygen species. Am J Respir Cell Mol Biol 26: 587–593, 2002.
19. Kostikas K, Papatheodorou G, Psathakis K, Panagou P, Loukides S. Oxidative stress in expired breath condensate of patients with COPD. Chest 124: 1373–1380, 2003.[CrossRef][Web of Science][Medline]
20. Lee JS, Kahlon SS, Culbreth R, Cooper AD Jr. Modulation of monocyte chemokine production and nuclear factor kappa B activity by oxidants. J Interferon Cytokine Res 19: 761–767, 1999.[CrossRef][Web of Science][Medline]
21. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 312: 159–163, 1985.[Abstract]
22. McCord JM, Fridovich I. The utility of superoxide dismutase in studying free radical reactions. II. The mechanism of the mediation of cytochrome c reduction by a variety of electron carriers. J Biol Chem 245: 1374–1377, 1970.
23. Mitra S, Abraham E. Participation of superoxide in neutrophil activation and cytokine production. Biochim Biophys Acta 1762: 732–741, 2006.[Medline]
24. Nalini S, Mathan MM, Balasubramanian KA. Oxygen free radical induced damage during intestinal ischemia/reperfusion in normal and xanthine oxidase deficient rats. Mol Cell Biochem 124: 59–66, 1993.[CrossRef][Web of Science][Medline]
25. Newman WH, Zunzunegui RG, Warejcka DJ, Dalton ML, Castresana MR. A reactive oxygen-generating system activates nuclear factor-kappaB and releases tumor necrosis factor-alpha in coronary smooth muscle cells. J Surg Res 85: 142–147, 1999.[CrossRef][Web of Science][Medline]
26. Park JS, Gamboni-Robertson F, He Q, Svetkauskaite D, Kim JY, Strassheim D, Sohn JW, Yamada S, Maruyama I, Banerjee A, Ishizaka A, Abraham E. High mobility group box 1 protein interacts with multiple Toll-like receptors. Am J Physiol Cell Physiol 290: C917–C924, 2006.
27. Polderman KH, Girbes AR. Drug intervention trials in sepsis: divergent results. Lancet 363: 1721–1723, 2004.[CrossRef][Web of Science][Medline]
28. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085–2088, 1998.
29. Poulsen JP, Oyasaeter S, Sanderud J, Rognum TO, Saugstad OD. Hypoxanthine, xanthine, and uric acid concentrations in the cerebrospinal fluid, plasma, and urine of hypoxemic pigs. Pediatr Res 28: 477–481, 1990.[Web of Science][Medline]
30. Radi R, Rubbo H, Bush K, Freeman BA. Xanthine oxidase binding to glycosaminoglycans: kinetics and superoxide dismutase interactions of immobilized xanthine oxidase-heparin complexes. Arch Biochem Biophys 339: 125–135, 1997.[CrossRef][Web of Science][Medline]
31. Rouquette M, Page S, Bryant R, Benboubetra M, Stevens CR, Blake DR, Whish WD, Harrison R, Tosh D. Xanthine oxidoreductase is asymmetrically localised on the outer surface of human endothelial and epithelial cells in culture. FEBS Lett 426: 397–401, 1998.[CrossRef][Web of Science][Medline]
32. Schwartz MD, Repine JE, Abraham E. Xanthine oxidase-derived oxygen radicals increase lung cytokine expression in mice subjected to hemorrhagic shock. Am J Respir Cell Mol Biol 12: 434–440, 1995.[Abstract]
33. Sekar RB, Periasamy A. Fluorescence resonance energy transfer (FRET) microscopy imaging of live cell protein localizations. J Cell Biol 160: 629–633, 2003.
34. Shenkar R, Abraham E. Mechanisms of lung neutrophil activation after hemorrhage or endotoxemia: roles of reactive oxygen intermediates, NF-kappa B, and cyclic AMP response element binding protein. J Immunol 163: 954–962, 1999.
35. Shenkar R, Schwartz MD, Terada LS, Repine JE, McCord J, Abraham E. Hemorrhage activates NF-
B in murine lung mononuclear cells in vivo. Am J Physiol Lung Cell Mol Physiol 270: L729–L735, 1996.
36. Shimamoto A, Chong AJ, Yada M, Shomura S, Takayama H, Fleisig AJ, Agnew ML, Hampton CR, Rothnie CL, Spring DJ, Pohlman TH, Shimpo H, Verrier ED. Inhibition of Toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury. Circulation 114: I270–I274, 2006.[Web of Science][Medline]
37. Stapel H, Kim SC, Osterkamp S, Knuefermann P, Hoeft A, Meyer R, Grohe C, Baumgarten G. Toll-like receptor 4 modulates myocardial ischaemia-reperfusion injury: role of matrix metalloproteinases. Eur J Heart Fail 8: 665–672, 2006.[CrossRef][Web of Science][Medline]
38. Strassheim D, Asehnoune K, Park JS, Kim JY, He Q, Richter D, Mitra S, Arcaroli J, Kuhn K, Abraham E. Modulation of bone marrow-derived neutrophil signaling by H2O2: disparate effects on kinases, NF-
B, and cytokine expression. Am J Physiol Cell Physiol 286: C683–C692, 2004.
39. Taggart DP, Young V, Hooper J, Kemp M, Walesby R, Magee P, Wright JE. Lack of cardioprotective efficacy of allopurinol in coronary artery surgery. Br Heart J 71: 177–181, 1994.
40. Tsuruta Y, Park YJ, Siegal GP, Liu G, Abraham E. Involvement of vitronectin in lipopolysaccaride-induced acute lung injury. J Immunol 179: 7079–7086, 2007.
41. Warren BL, Eid A, Singer P, Pillay SS, Carl P, Novak I, Chalupa P, Atherstone A, Penzes I, Kubler A, Knaub S, Keinecke HO, Heinrichs H, Schindel F, Juers M, Bone RC, Opal SM. Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA 286: 1869–1878, 2001.
42. Yang KY, Arcaroli JJ, Abraham E. Early alterations in neutrophil activation are associated with outcome in acute lung injury. Am J Respir Crit Care Med 167: 1567–1574, 2003.
43. Yum HK, Arcaroli J, Kupfner J, Shenkar R, Penninger JM, Sasaki T, Yang KY, Park JS, Abraham E. Involvement of phosphoinositide 3-kinases in neutrophil activation and the development of acute lung injury. J Immunol 167: 6601–6608, 2001.
44. Zmijewski JW, Zhao X, Xu Z, Abraham E. Exposure to hydrogen peroxide diminishes NF-
B activation, I
B-
degradation, and proteasome activity in neutrophils. Am J Physiol Cell Physiol 293: C255–C266, 2007.
This article has been cited by other articles:
![]() |
J. W. Zmijewski, E. Lorne, X. Zhao, Y. Tsuruta, Y. Sha, G. Liu, and E. Abraham Antiinflammatory Effects of Hydrogen Peroxide in Neutrophil Activation and Acute Lung Injury Am. J. Respir. Crit. Care Med., April 15, 2009; 179(8): 694 - 704. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Zmijewski, E. Lorne, S. Banerjee, and E. Abraham Participation of mitochondrial respiratory complex III in neutrophil activation and lung injury Am J Physiol Lung Cell Mol Physiol, April 1, 2009; 296(4): L624 - L634. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhao, J. W. Zmijewski, E. Lorne, G. Liu, Y.-J. Park, Y. Tsuruta, and E. Abraham Activation of AMPK attenuates neutrophil proinflammatory activity and decreases the severity of acute lung injury Am J Physiol Lung Cell Mol Physiol, September 1, 2008; 295(3): L497 - L504. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |